Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 27 6 2019
medline: 27 6 2019
entrez: 26 6 2019
Statut: ppublish

Résumé

Since the publication of this paper, the authors noticed that Corentin Richard was not credited as contributing equally to the paper. He should be considered as a joint first author with Jean-David Fumet.

Identifiants

pubmed: 31235866
doi: 10.1038/s41416-019-0512-8
pii: 10.1038/s41416-019-0512-8
pmc: PMC6738095
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

283

Commentaires et corrections

Type : ErratumFor

Auteurs

Jean-David Fumet (JD)

Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.
University of Burgundy-Franche Comté, Dijon, France.

Corentin Richard (C)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.
University of Burgundy-Franche Comté, Dijon, France.

Fanny Ledys (F)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.
University of Burgundy-Franche Comté, Dijon, France.

Quentin Klopfenstein (Q)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.

Philippe Joubert (P)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.

Bertrand Routy (B)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada.

Caroline Truntzer (C)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.

Andréanne Gagné (A)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.

Marc-André Hamel (MA)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.

Camila Figueiredo Guimaraes (CF)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.

Bruno Coudert (B)

Department of Medical Oncology, Center GF Leclerc, Dijon, France.

Laurent Arnould (L)

Department of Pathology, Center GF Leclerc, Dijon, France.

Laure Favier (L)

Department of Medical Oncology, Center GF Leclerc, Dijon, France.

Aurélie Lagrange (A)

Department of Medical Oncology, Center GF Leclerc, Dijon, France.

Sylvain Ladoire (S)

Department of Medical Oncology, Center GF Leclerc, Dijon, France.
University of Burgundy-Franche Comté, Dijon, France.

Pierre Saintigny (P)

Department of Medical Oncology, Center Leon Berard, Lyon, France.

Sandra Ortiz-Cuaran (S)

Department of Medical Oncology, Center Leon Berard, Lyon, France.

Maurice Perol (M)

Department of Medical Oncology, Center Leon Berard, Lyon, France.

Pascal Foucher (P)

Department of Thoracic Oncology, Dijon University Hospital, Dijon, France.

Paul Hofman (P)

Laboratory of Clinical and Experimental Pathology, FHU OncoAge, Nice University Hospital, Université Côte d'Azur, Nice, France.
Hospital-Integrated Biobank (BB-0033-00025), FHU OncoAge, Nice University Hospital, Université Côte d'Azur, Nice, France.

Marius Ilie (M)

Laboratory of Clinical and Experimental Pathology, FHU OncoAge, Nice University Hospital, Université Côte d'Azur, Nice, France.
Hospital-Integrated Biobank (BB-0033-00025), FHU OncoAge, Nice University Hospital, Université Côte d'Azur, Nice, France.

Sandy Chevrier (S)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.

Romain Boidot (R)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.

Valentin Derangere (V)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.

François Ghiringhelli (F)

Department of Medical Oncology, Center GF Leclerc, Dijon, France. fghiringhelli@cgfl.fr.
Research Platform in Biological Oncology, Dijon, France. fghiringhelli@cgfl.fr.
GIMI Genetic and Immunology Medical Institute, Dijon, France. fghiringhelli@cgfl.fr.
University of Burgundy-Franche Comté, Dijon, France. fghiringhelli@cgfl.fr.
INSERM UMR1231, Dijon, France. fghiringhelli@cgfl.fr.

Classifications MeSH